PMID- 23383514 OWN - NLM STAT- MEDLINE DCOM- 20130319 LR - 20130206 IS - 0001-6209 (Print) IS - 0001-6209 (Linking) VI - 52 IP - 11 DP - 2012 Nov 4 TI - [Cloning and characterization of a new antibacterial target, 3,4-dihydroxy-2-butanone-4-phosphate synthase]. PG - 1415-20 AB - OBJECTIVE: Riboflavin, called generally vitamin B12, is the precursor of cofactor flavin adenine dinucleotide (FAD) and flavin mononucleotide, which plays crucial roles in the biosynthesis of organisms. Bacteria need to synthesize riboflavin to maintain their survival and proliferation if they cannot obtain flavin from the surroundings. 3,4-Dihydroxy-2-butanone4-phosphate synthase (DHBPs) is one of the key enzymes in biosynthesis of riboflavin. In the presence of Mg2+, DHBPs can degrade ribulose-5-phosphate (Ru5P) into formate and 3,4-dihydroxy-2-butanone-4-phosphate (DHBP). Potentially, these enzymes related to biosynthesis and metabolism of riboflavin, including DHBPs, may serve as the target for new antibacterial drug. In order to determine the three-dimensional structure and screen small molecule of inhibitor of DHBPs, we expressed and purified DHBPs from Streptococcus pneumonia (S. pn), and characterized the activity of this enzyme. METHOD: DHBPs gene was amplified by PCR, and over-expression plasmid pW28-DHBPs was constructed. pW28-DHBPs was transformed into Escherichia coli BL21 (DE3) to express DHBPs; the recombinant protein was purified by nickel column and ion-exchange column. The enzymatic activity was tested using spectroscopy. RESULTS: The plasmid of pW28-DHBPs was verified by restrictive enzyme digestion and sequencing. Soluble DHBPs was expressed in E. coli BL21, and purified with 95% purity. The result of size exclusion chromatography indicates that DHBPs was dimer in solution. Additionally, the recombinant protein has activity to hydrolyze Ru5P into formate and DHBP in the conditions of pH 7.5 and 25 degrees C and in the presence of Mg2+. CONCLUSIONS: DHBPs could be highly expressed in soluble form in E. coli BL21 strain, and the recombinant protein has activity to hydrolyze Ru5P. FAU - Jin, Li AU - Jin L AD - Key Laboratory of Molecular Biology of Infectious Diseases, Ministry of Education, Faculty of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China. lijin2011@126.com FAU - Zhou, Hua AU - Zhou H FAU - Zhao, Shasha AU - Zhao S FAU - Yang, Wei AU - Yang W FAU - Niu, Siqiang AU - Niu S FAU - Wang, Deqiang AU - Wang D LA - chi PT - English Abstract PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Wei Sheng Wu Xue Bao JT - Wei sheng wu xue bao = Acta microbiologica Sinica JID - 21610860R RN - 0 (Anti-Bacterial Agents) RN - 0 (Bacterial Proteins) RN - 0 (Enzyme Inhibitors) RN - 0 (Ribulosephosphates) RN - 4151-19-3 (ribulose 5-phosphate) RN - EC 5.4.- (Intramolecular Transferases) RN - EC 5.4.- (L-3,4-dihydroxy-2-butanone-4-phosphate synthase) SB - IM MH - Anti-Bacterial Agents/*pharmacology MH - Bacterial Proteins/antagonists & inhibitors/*chemistry/*genetics/metabolism MH - *Cloning, Molecular MH - Drug Resistance, Bacterial MH - Enzyme Inhibitors/pharmacology MH - Intramolecular Transferases/antagonists & inhibitors/*chemistry/*genetics/metabolism MH - Ribulosephosphates/metabolism MH - Streptococcus pneumoniae/drug effects/*enzymology/genetics/metabolism EDAT- 2013/02/07 06:00 MHDA- 2013/03/21 06:00 CRDT- 2013/02/07 06:00 PHST- 2013/02/07 06:00 [entrez] PHST- 2013/02/07 06:00 [pubmed] PHST- 2013/03/21 06:00 [medline] PST - ppublish SO - Wei Sheng Wu Xue Bao. 2012 Nov 4;52(11):1415-20.